The Oxford startup raised the capital from Microsoft's venture fund and Mayfield following its success in the Female Founders Competition.
"We are so excited to name iLoF a winner of the Female Founders Competition and invest $1 million alongside Mayfield. iLoF’s technology promises to create effective treatments tailored for the individual, which will change healthcare trajectories for millions of people living with complex disorders. Their mission is humbling, and we are thrilled to support this company with our investment and as a board observer."
The seven-figure equity round was led by Insurtech Gateway with backing from the Development Bank of Wales.
"Coincover helps crypto businesses to address the security concerns of the cautious investor and delivers the trust mark they need to stand out in a crowded and wary market. We are the only company in the world with a security product that is backed by Lloyds of London, providing protection from cryptocurrency theft at the individual level and an opportunity to maximise business revenue by enabling our partners to build systems that creates strong trust with their clients."
The funding coincides with a worldwide partnership to launch the new buildable Kano PC.
"The Education sector is undergoing massive change enabled by technology, and our collaboration with Kano is truly advancing the vision of “technology for all,”"
— Jordan Chrysafidis, General Manager, Worldwide Education Device Sales
Epidarex Capital led the seed round to help the Edinburgh spin-out advance its tumour-associated macrophage platform.
"Decades of research into macrophage biology, particularly that of tumour-associated macrophages, have made it very clear to me that this is an area of significant untapped potential for the development of novel cancer therapeutics. The creation of Macomics based on the research of my group at the University of Edinburgh provides the team with an exciting opportunity to develop new effective cancer drugs against macrophage targets, that will bring real clinical benefit to many more patients suffering from cancer."
— Jeffrey Pollard, Director of the MRC Centre for Reproductive Health at the University of Edinburgh
IQ Capital led the Series A financing to support the cybersecurity provider's continued growth.
"Cyber security has become increasingly important, more so with the global shift to remote working, especially for the SMB market that CyberSmart supports. CyberSmart has already achieved great success by identifying SMBs as a market segment that was underserved by the cyber security industry. The company has a strong product-market fit, is hitting targets well ahead of schedule, and has secured strategic partnerships to further market penetration within the UK and internationally. The team has been incredible to work with over the last year and demonstrated thought leadership and deep understanding of the needs of SMBs, enabling CyberSmart to provide automated, and simple to implement protection for firms with 1-20+ employees"
